MichaelOKochMDFACS
Urology • Indianapolis, INSurgical Oncology
Chairman and Professor of Urology Indiana University School of Medicine
Dr. Koch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
535 Barnhill Dr
# ROUTE420
Indianapolis, IN 46202Phone+1 317-944-7338Fax+1 317-278-0499
Education & Training
Vanderbilt University Medical CenterResidency, Urology, 1984 - 1987
Dartmouth-Hitchcock Medical Center1984
Geisel School of Medicine at DartmouthClass of 1981
Certifications & Licensure
IN State Medical License 1998 - 2025
TN State Medical License 1986 - 1999- American Board of Urology Urology
Awards, Honors, & Recognition
- America's Top Doctors Castle Connolly, 2011-2015
- America's Top Doctors for Cancer Castle Connolly, 2010-2015
- Indianapolis Monthly Castle Connolly, 2007, 2009-2014
Clinical Trials
- Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence Start of enrollment: 1999 Jun 14
- High-Intensity Focused Ultrasound in Treating Patients With Locally Recurrent Prostate Cancer Start of enrollment: 2001 Oct 01
- Ultrasound in Treating Patients With Prostate Cancer Confined to the Prostate Start of enrollment: 2001 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 37 citationsLow molecular weight heparin and radical prostatectomy: a prospective analysis of safety and side effects.Michael O. Koch, Joseph A. Smith
Prostate Cancer and Prostatic Diseases. 1997-12-01 - 152 citationsAlvimopan accelerates gastrointestinal recovery after radical cystectomy: A multicenter randomized placebo-controlled trialCheryl T. Lee, Sam S. Chang, Ashish M. Kamat, Gilad E. Amiel, Timothy L. Beard
European Urology. 2014-08-01 - 18 citationsNeoadjuvant dasatinib for muscle-invasive bladder cancer with tissue analysis of biologic activityNoah M. Hahn, Beatrice S. Knudsen, Siamak Daneshmand, Michael O. Koch, Richard Bihrle
Urologic Oncology. 2016-01-01
Journal Articles
- A Parallel Randomized Clinical Trial Examining the Return of Urinary Continence After Robot-Assisted Radical Prostatectomy with or Without a Small Intestinal Submucosa...Naveen Kella, Michelle A Boger, Michael O Koch, Steven M Lucas, Chandru P Sundaram, Clinton D Bahler, Thomas A Gardner, The Journal of Urology
Authored Content
- Targeting the Programmed Cell Death-1 Pathway in Genitourinary Tumors: Current Progress and Future PerspectivesSeptember 2018
Press Mentions
Illuccix Approved by FDA as Prostate Cancer Imaging AgentApril 15th, 2022- First Patients Dosed with Illuccix® - Telix's Approved Prostate Cancer Imaging AgentApril 14th, 2022
The End to WHAT Controversy?June 24th, 2016- Join now to see all
Professional Memberships
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
